Novartis pays $85m to shed Array, and other recent brush offs
This article was originally published in Scrip
Executive Summary
Array BioPharma has joined an assortment of companies that have lost their big pharma partners in recent days. Array has been relinquished by Novartis, Dynavax discarded by GlaxoSmithKline, Grünenthal abandoned by Actavis, and Pozen deserted by Sanofi, all in the past week.